Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population

The population prevalence of cardiac transthyretin amyloidosis (ATTR) caused by pathogenic variation in the TTR gene (vATTR) is unknown.